Location History:
- Montreal, CA (2000 - 2001)
- St-Lazare, CA (2009)
Company Filing History:
3 out of 76 
1 out of 4,770 
Years Active: 2000-2009
Title: The Innovative Contributions of Chad Dalton
Introduction
Chad Dalton is a notable inventor based in St-Lazare, CA. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on novel compounds and processes that have the potential to enhance therapeutic options.
Latest Patents
One of Chad Dalton's latest patents is for a polymorphic form of montelukast sodium. This invention provides a novel polymorphic form of montelukast sodium, along with methods of using and pharmaceutical compositions containing this new form. Additionally, the patent includes montelukast sodium: acetonitrile solvates, which serve as intermediates in the formation of crystalline montelukast sodium. Another significant patent involves the synthesis of 4-[(5-substituted phenyl)-3-substituted-1H-pyrazol-1-yl]benzenesulfonamide. This invention encompasses a novel process for synthesizing the compound represented by a specific formula.
Career Highlights
Chad Dalton has worked with prominent companies in the pharmaceutical industry, including Merck Frosst Canada & Co. and Merck & Co., Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Chad has collaborated with talented individuals such as Sophie-Dorothee Clas and Paul O'Shea. These partnerships have likely enriched his work and led to further advancements in his field.
Conclusion
Chad Dalton's innovative contributions to pharmaceuticals demonstrate his commitment to advancing medical science. His patents reflect a dedication to developing new therapeutic options that can benefit patients worldwide.